{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:59Z","timestamp":1772119739781,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Shanghai","award":["22ZR1418300"],"award-info":[{"award-number":["22ZR1418300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 21706072"],"award-info":[{"award-number":["No. 21706072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10412-7","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:13:17Z","timestamp":1741849997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Site-specific PEGylation of recombinant protein SAC-TRAIL and characterization of the effect on antitumor activity"],"prefix":"10.1007","volume":"52","author":[{"given":"Shuting","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuedong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zebo","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"10412_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00253-022-11807-3","volume":"106","author":"J Zhang","year":"2022","unstructured":"Zhang J, Dong WY, Ren YH et al (2022) SAC-TRAIL, a novel anticancer fusion protein: expression, purification, and functional characterization. Appl Microbiol Biotechnol 106:1511\u20131520","journal-title":"Appl Microbiol Biotechnol"},{"key":"10412_CR2","doi-asserted-by":"publisher","first-page":"12831","DOI":"10.1074\/jbc.M700438200","volume":"282","author":"SL Kohlhaas","year":"2007","unstructured":"Kohlhaas SL, Craxton A, Sun XM et al (2007) Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem 282:12831\u201312841","journal-title":"J Biol Chem"},{"key":"10412_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3858\/emm.2012.44.11.074","volume":"44","author":"OW Seo","year":"2012","unstructured":"Seo OW, Kim JH, Lee KS et al (2012) Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-\u03baB-dependent cFLIP expression in HeLa cells. Exp Mol Med 44:653\u2013664","journal-title":"Exp Mol Med"},{"key":"10412_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/BST20220098","volume":"51","author":"FD Cristofano","year":"2023","unstructured":"Cristofano FD, George A, Tajiknia V et al (2023) Therapeutic targeting of TRAIL death receptors. Biochem Soc Trans 51:57\u201370","journal-title":"Biochem Soc Trans"},{"key":"10412_CR5","doi-asserted-by":"publisher","first-page":"116041","DOI":"10.1016\/j.bcp.2024.116041","volume":"221","author":"A Maji","year":"2024","unstructured":"Maji A, Paul A, Sarkar A et al (2024) Significance of TRAIL\/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: implications for cancer-targeted therapeutics. Biochem Pharmacol 221:116041","journal-title":"Biochem Pharmacol"},{"key":"10412_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2017.04.026","volume":"400","author":"TB Prigozhina","year":"2017","unstructured":"Prigozhina TB, Szafer F, Aronin A et al (2017) Fn14\u00b7TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog. Cancer Letter 400:99\u2013109","journal-title":"Cancer Letter"},{"key":"10412_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pep.2016.02.015","volume":"122","author":"M Sang","year":"2016","unstructured":"Sang M, Zhang JX, Li B et al (2016) TRAIL-CM4 fusion protein shows in vitro antibacterial activity and a stronger antitumor activity than solo TRAIL protein. Protein Exp Purif 122:82\u201389","journal-title":"Protein Exp Purif"},{"key":"10412_CR8","first-page":"1155","volume":"184","author":"J Zhang","year":"2018","unstructured":"Zhang J, Sun AY, Dong YG et al (2018) Recombinant production and characterization of SAC, the core domain of Par-4, by SUMO fusion system. Appl Microbiol Biotechnol 184:1155\u20131167","journal-title":"Appl Microbiol Biotechnol"},{"key":"10412_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fpls.2015.00822","volume":"6","author":"S Sarkar","year":"2015","unstructured":"Sarkar S, Jain S, Rai V et al (2015) Plant-derived SAC domain of PAR-4 (Prostate apoptosis response 4) exhibits growth inhibitory effects in prostate cancer cells. Front Plant Sci 6:822","journal-title":"Front Plant Sci"},{"key":"10412_CR10","doi-asserted-by":"publisher","first-page":"22641","DOI":"10.18632\/oncotarget.4010","volume":"6","author":"S Meynier","year":"2015","unstructured":"Meynier S, Kramer M, Ribaux P et al (2015) Role of PAR-4 in ovarian cancer. Oncotarget 6:22641\u201322652","journal-title":"Oncotarget"},{"key":"10412_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1021\/acs.bioconjchem.2c00059","volume":"33","author":"H Hayun","year":"2022","unstructured":"Hayun H, Arkadash V, Sananes A et al (2022) Bioorthogonal pegylation prolongs the elimination half-life of N-TIMP2 while retaining MMP Inhibition. Bioconjug Chem 33:795\u2013806","journal-title":"Bioconjug Chem"},{"key":"10412_CR12","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.3390\/ijms24043387","volume":"24","author":"MY Xu","year":"2023","unstructured":"Xu MY, Bi JH, Liang B et al (2023) PEGylation prolongs the half-life of equine anti-SARS-CoV-2 specific F(ab\u2019)2. Int J Mol Sci 24:3387","journal-title":"Int J Mol Sci"},{"key":"10412_CR13","doi-asserted-by":"crossref","unstructured":"Vanderschuren K, Arranz-Gibert P, Khang M et al (2022) Tuning protein half-life in mouse using sequence-defined biopolymers functionalized with lipids. Proceedings of the National Academy of Sciences 119: e2103099119","DOI":"10.1073\/pnas.2103099119"},{"key":"10412_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12195-021-00681-0","volume":"14","author":"BJ Kane","year":"2021","unstructured":"Kane BJ, Fettis MM, Farhadi S et al (2021) Site-specific cross-linking of galectin-1 homodimers via poly(ethylene glycol) bismaleimide. Cell Mol Bioeng 14:523\u2013534","journal-title":"Cell Mol Bioeng"},{"key":"10412_CR15","doi-asserted-by":"publisher","first-page":"11785","DOI":"10.1021\/acs.iecr.6b03122","volume":"55","author":"XJ Shang","year":"2016","unstructured":"Shang XJ, Brandon C, Brian M et al (2016) Modeling and optimization of protein pegylation. Ind Eng Chem Res 55:11785\u201311794","journal-title":"Ind Eng Chem Res"},{"key":"10412_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1021\/acs.bioconjchem.7b00770","volume":"29","author":"FB Qi","year":"2018","unstructured":"Qi FB, Hu CY, Yu WL et al (2018) Conjugation with eight-arm PEG markedly improves the in vitro activity and prolongs the blood circulation of staphylokinase. Bioconjug Chem 29:451\u2013458","journal-title":"Bioconjug Chem"},{"key":"10412_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/bc049713n","volume":"16","author":"MS Rosendahl","year":"2005","unstructured":"Rosendahl MS, Doherty DH, Smith DJ et al (2005) A long-acting, highly potent interferon alpha-2 conjugate created using site-specific pegylation. Bioconjug Chem 16:200\u2013207","journal-title":"Bioconjug Chem"},{"key":"10412_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/bit.28360","volume":"120","author":"T Batugal","year":"2023","unstructured":"Batugal T, Pendyala G, Tomasovic L et al (2023) Engineering active lysostaphin variants that incorporate noncanonical amino acids and characterizing the effects of site-specific pegylation. Biotechnol Bioeng 120:1694\u20131701","journal-title":"Biotechnol Bioeng"},{"key":"10412_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"MJ Roberts","year":"2012","unstructured":"Roberts MJ, Bentley MD, Harris JM (2012) Chemistry for peptide and protein pegylation. Adv Drug Deliv Rev 54:459\u2013476","journal-title":"Adv Drug Deliv Rev"},{"key":"10412_CR20","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1016\/j.biomaterials.2013.08.020","volume":"34","author":"LQ Pan","year":"2013","unstructured":"Pan LQ, Wang HB, Lai J et al (2013) Site-specific pegylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). Biomaterials 34:9115\u20139123","journal-title":"Biomaterials"},{"key":"10412_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/nar\/gkw408","volume":"44","author":"H Ashkenazy","year":"2016","unstructured":"Ashkenazy H, Abadi S, Martz E et al (2016) ConSurf: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res 44:344\u2013350","journal-title":"Nucleic Acids Res"},{"key":"10412_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acs.bioconjchem.7b00795","volume":"29","author":"N Forte","year":"2018","unstructured":"Forte N, Livanos M, Miranda E et al (2018) Tuning the hydrolytic stability of next generation maleimide cross-linkers enables access to albumin-antibody fragment conjugates and tri-scFvs. Bioconjug Chem 29:486\u2013492","journal-title":"Bioconjug Chem"},{"key":"10412_CR23","first-page":"e01009","volume":"54","author":"JHPM Santos","year":"2018","unstructured":"Santos JHPM, Torres-Obreque KM, Meneguetti GP et al (2018) Protein pegylation for the design of biobetters: from reaction to purification processes. Brazilian J Pharm Sci 54:e01009","journal-title":"Brazilian J Pharm Sci"},{"key":"10412_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/00498254.2024.2303586","volume":"54","author":"L Salphati","year":"2024","unstructured":"Salphati L, Pang J, Alicke B et al (2024) Preclinical characterization of the absorption and disposition of the brain penetrant PI3K\/mTOR inhibitor paxalisib and prediction of its pharmacokinetics and efficacy in human. Xenobiotica 54:64\u201374","journal-title":"Xenobiotica"},{"key":"10412_CR25","doi-asserted-by":"publisher","first-page":"121152","DOI":"10.1016\/j.ijpharm.2021.121152","volume":"609","author":"YW Wang","year":"2021","unstructured":"Wang YW, Niu SP, Li BZ et al (2021) Improvement of stability and in vivo antioxidant effect of human glutathione peroxidase mutant by pegylation. Int J Pharm 609:121152","journal-title":"Int J Pharm"},{"key":"10412_CR26","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1021\/acs.biomac.2c01192","volume":"23","author":"A Meziadi","year":"2022","unstructured":"Meziadi A, Zuberi N, Haan HW et al (2022) Overcoming pegprotein mutual repulsion to improve the efficiency of pegylation. Biomacromolecules 23:4948\u20134956","journal-title":"Biomacromolecules"},{"key":"10412_CR27","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1016\/j.bmcl.2004.09.059","volume":"14","author":"A Deiters","year":"2004","unstructured":"Deiters A, Cropp TA, Summerer D et al (2004) Site-specific pegylation of proteins containing unnatural amino acids. Bioorg Med Chem Lett 14:5743\u20135745","journal-title":"Bioorg Med Chem Lett"},{"key":"10412_CR28","first-page":"337","volume":"11","author":"P Mishra","year":"2016","unstructured":"Mishra P, Nayak B, Dey RK (2016) PEGylation in anti-cancer therapy: an overview. Asian J Pharm Sci 11:337\u2013348","journal-title":"Asian J Pharm Sci"},{"key":"10412_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejpb.2023.09.017","volume":"192","author":"K Meiners","year":"2023","unstructured":"Meiners K, Hamm P, Gutmann M et al (2023) Site-specific pegylation of recombinant tissue-type plasminogen activator. Eur J Pharm Biopharm 192:79\u201387","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10412-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10412-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10412-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:25:08Z","timestamp":1766852708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10412-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10412"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10412-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5885641\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were approved by the East China University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have agreed to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}